EMEA-001739-PIP02-16-M01
Key facts
| Active substance |
|
| Therapeutic area |
Pain
|
| Decision number |
P/0177/2022
|
| PIP number |
EMEA-001739-PIP02-16-M01
|
| Pharmaceutical form(s) |
Nasal spray, solution
|
| Condition(s) / indication(s) |
Treatment of acute pain
|
| Route(s) of administration |
Intranasal use
|
| Contact for public enquiries |
Cessatech A/S
E-mail: info@cessatech.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|